Bibliographic Citation
| - Berghmans T., Scherpereel A., Meert A.-P., Giner V., Lecomte Julie, Lafitte J.-J., Leclercq N., Paesmans M., Sculier J.-P., Van Houtte P., Roelandts M., Thiriaux J., Alexopoulos C. G., Vaslamatzis M., Holbrechts S., Wackenier P., Recloux P., Bonduelle Y., Corhay Jean-Louis, Van Cutsem O., Mairesse M., Efremidis A., Koumakis G., Florin M. C., Maetz E., Strecker A., Richez M., Ficheroulle X., Colinet B., Collon T., Zacharias C., Bensliman S., Drowart A., Prigogine T., Brohée D., Stach B., Ravez P., Berchier M. C., Amourette J., Tagnon A., Kroll F., Steenhouwer F.. A Phase III randomized study comparing a chemotherapy with cisplatin and etoposide to a etoposide regimen without cisplatin for patients with extensive small-cell lung cancer. 2017
|